Testagen

ExperimentalShort Peptide Bioregulator (Endocrine Research)Experimental

Testagen is a short tetrapeptide bioregulator commonly referenced as KEDG and used in research contexts exploring endocrine related cellular regulation and signaling.

Calculate Dose

For research use only.

Key Facts

CAS: 1026993-38-3
Molecular Weight (MW): 447.44 g/mol
Half-life: Not established (limited public PK data; primarily research context)
Unit: mg
Administration Route: Oral or sublingual (common commercial formats); injectable research use exists by supplier
Frequency: Once daily (typical research pattern)
Last updated: 3/1/2026
Targets: Cellular gene expression pathways (proposed)Endocrine tissue signaling (research context)

Overview

Testagen is a short tetrapeptide bioregulator commonly referenced as KEDG and used in research contexts exploring endocrine related cellular regulation and signaling.

Protocol

Dosage Range: 5-20 mg daily (research context; not clinically established)
Frequency: Once daily (typical research pattern)
Cycle: 10-30 days common in bioregulator style protocols (research context)
Administration Route: Oral or sublingual (common commercial formats); injectable research use exists by supplier
Reconstitution Guide: If lyophilized: reconstitute with bacteriostatic water per lab SOP (research only)

Science

Mechanism of Action

Proposed to influence cellular regulatory signaling and gene expression in endocrine related experimental models; human clinical efficacy not established.

Targets

Cellular gene expression pathways (proposed)Endocrine tissue signaling (research context)

Studies

— Journal/year not available
— Journal/year not available

Benefits

Studied for endocrine system signaling researchReproductive and hormonal pathway research applicationsCellular stress resilience research in experimental models